Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis

被引：0
|
作者：
Sue Ping Thang
Mei Sim Lung
Grace Kong
Michael S. Hofman
Jason Callahan
Michael Michael
Rodney J. Hicks
机构：
[1] Centre for Cancer Imaging,Department of Nuclear Medicine and PET
[2] Peter MacCallum Cancer Centre,undefined
[3] Division of Cancer Medicine,undefined
[4] Neuroendocrine Tumour Unit,undefined
[5] Peter MacCallum Cancer Centre,undefined
[6] Singapore General Hospital,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
On page 4 of the original version of this article, the text “Eight (29%) of the patients had significant FDG-avid disease (i.e. with intensity above liver parenchyma) prior to treatment” needs to be corrected.
引用
收藏
页码：323 / 323
相关论文
共 48 条
  • [1] Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
    Sue Ping Thang
    Mei Sim Lung
    Grace Kong
    Michael S. Hofman
    Jason Callahan
    Michael Michael
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 262 - 277
  • [2] Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
    Thang, Sue Ping
    Lung, Mei Sim
    Kong, Grace
    Hofman, Michael S.
    Callahan, Jason
    Michael, Michael
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (02) : 262 - 277
  • [3] Peptide receptor radionuclide therapy (PRRT) in ENETS Grade 3 (G3) Neuroendocrine Neoplasia (NEN) - a single-institution retrospective analysis
    Thang, S.
    Lung, M.
    Kong, G.
    Hofman, M.
    Callahan, J.
    Michael, M.
    Hicks, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S325 - S326
  • [4] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Progressive Grade 3 Neuroendocrine Neoplasms (NEN)
    Zhang, Jingjing
    Kulkarni, Harshad
    Singh, Aviral
    Niepsch, Karin
    Mueller, Dirk
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [5] Favourable Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) for Treatment of Metastatic Rectal Neuroendocrine Neoplasia (NEN)
    Kong, G.
    Grozinsky-Glasberg, S.
    Akhurst, T.
    Hofman, M.
    Meirovitz, A.
    Maimon, O.
    Schwartz, A.
    Michael, M.
    Gross, D. J.
    Hicks, R.
    NEUROENDOCRINOLOGY, 2018, 106 : 247 - 247
  • [6] Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
    Kong, Grace
    Grozinsky-Glasberg, Simona
    Hofman, Michael S.
    Akhurst, Tim
    Meirovitz, Amichay
    Maimon, Ofra
    Krausz, Yodphat
    Godefroy, Jeremy
    Michael, Michael
    Gross, David J.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 718 - 727
  • [7] Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
    Grace Kong
    Simona Grozinsky-Glasberg
    Michael S. Hofman
    Tim Akhurst
    Amichay Meirovitz
    Ofra Maimon
    Yodphat Krausz
    Jeremy Godefroy
    Michael Michael
    David J. Gross
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 718 - 727
  • [8] Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic Grade 3 Neuroendocrine Neoplasms: A Retrospective International Multicenter Study
    Skovgaard, D.
    Fazio, N.
    Granberg, D.
    Grozinsky-Glasberg, S.
    Ahmadzadehfar, H.
    Zandee, W.
    Cwikla, J.
    Walter, M.
    Ringe, A.
    Frilling, A.
    Grana, C.
    Horbye, H.
    NEUROENDOCRINOLOGY, 2018, 106 : 258 - 258
  • [9] Single Institution Experience with Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ninatti, G.
    Girod, B.
    Ferri, V
    Guja, K.
    Song, H.
    Kunz, P.
    Fisher, G.
    Lagaru, A.
    Mari, Aparici C.
    NEUROENDOCRINOLOGY, 2020, 110 : 253 - 253
  • [10] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Kunz, Pamela L.
    Fisher, George A.
    Moradi, Farshad
    Davidzon, Guido Alejandro
    Franc, Benjamin Lewis
    Iagaru, Andrei
    Mari, Carina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345